Mineralized Enzyme-Based Biomaterials with Superior Bioactivities for Bone Regeneration
Source abstract
Abstract
The formation and metabolic balance of bone tissue is a controllable process of biomineralization, which is regulated by various cells, biomolecules, and ions. Enzyme molecules play an important role in this process, and alkaline phosphatase (ALP) is one of the most critical factors. In this study, inspired by the process of bone biomineralization, a biomimetic strategy is achieved for the preparation of mineralized ALP nanoparticles (MALPNs), by taking advantages of the unique reaction between ALP and calcium ions in Dulbecco's modified Eagle's medium. Benefiting from the mild biomineralization reaction, the MALPN system highly maintains the activity of ALP. Furthermore, the in vitro studies show that the MALPN system significantly enhances the proliferation of bone marrow mesenchymal stem cells and upregulates their osteogenic differentiation. When evaluated as synthetic graft materials for bone regeneration, the MALPN-incorporated gelatin methacryloyl graft shows excellent mechanical properties, a sustained release profile of ALP, and high biocompatibility and efficacy in guiding bone regeneration and vascularization for critical-sized rat calvarial defect. Moreover, we also demonstrate that the biomimetic mineralization strategy can be adopted for other proteins such as acid phosphatase, bovine serum albumin, fibrinogen, and gelatin, suggesting its universality for constructing mineralized protein-/enzyme-based bioactive materials for the application of tissue regeneration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Alkaline Phosphatase Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedic, Spinal Pain Research Institute, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, P. R. China
Institute of Translational Medicine, Shanghai University, Shanghai 200444, P. R. China
Funding
Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China · Science and Technology Innovation 2025 Major Special Programme of Ningbo
References (56)
Show source-provided references
1. 10.1007/s00586010028310.1007/s005860100283 ↗
2. 10.3390/ma1004033410.3390/ma10040334 ↗
3. 10.3390/ijms2203112810.3390/ijms22031128 ↗
4. 10.1016/j.actbio.2020.04.04910.1016/j.actbio.2020.04.049 ↗
5. 10.1021/acsami.8b0811910.1021/acsami.8b08119 ↗
6. 10.1021/acsbiomaterials.9b0085810.1021/acsbiomaterials.9b00858 ↗
7. 10.1002/adhm.20180070010.1002/adhm.201800700 ↗
8. 10.1039/d0bm01821j10.1039/d0bm01821j ↗
9. 10.1002/adhm.20180104410.1002/adhm.201801044 ↗
10. 10.1038/s41598-019-44268-210.1038/s41598-019-44268-2 ↗
11. 10.1002/adfm.20080081910.1002/adfm.200800819 ↗
12. 10.1074/jbc.m80320520010.1074/jbc.m803205200 ↗
13. 10.1016/s0378-5173(00)00423-310.1016/s0378-5173(00)00423-3 ↗
14. 10.1016/s0006-3495(93)81120-210.1016/s0006-3495(93)81120-2 ↗
15. 10.1021/acsnano.7b0180910.1021/acsnano.7b01809 ↗
16. 10.1016/j.spinee.2021.01.01910.1016/j.spinee.2021.01.019 ↗
17. 10.1038/s41467-017-01764-110.1038/s41467-017-01764-1 ↗
18. 10.1021/acsnano.9b0583610.1021/acsnano.9b05836 ↗
19. 10.1016/j.biomaterials.2009.05.02210.1016/j.biomaterials.2009.05.022 ↗
20. 10.1002/mabi.20110050110.1002/mabi.201100501 ↗
21. 10.1007/s12668-021-00886-710.1007/s12668-021-00886-7 ↗
22. 10.1016/j.cej.2019.04.01710.1016/j.cej.2019.04.017 ↗
23. Douglas T. E. L. · Acta Bioeng. Biomech. · 2016 · 18 · 51
24. 10.1016/j.biomaterials.2020.12038510.1016/j.biomaterials.2020.120385 ↗
25. 10.1016/j.compositesb.2021.10939610.1016/j.compositesb.2021.109396 ↗
26. 10.1016/j.jcis.2017.03.03210.1016/j.jcis.2017.03.032 ↗
27. 10.1038/s41598-020-67289-810.1038/s41598-020-67289-8 ↗
28. 10.1021/acsbiomaterials.1c0019610.1021/acsbiomaterials.1c00196 ↗
29. 10.1002/smll.20180432110.1002/smll.201804321 ↗
30. 10.1016/j.ceramint.2020.05.14210.1016/j.ceramint.2020.05.142 ↗
31. 10.1039/d0cp00797h10.1039/d0cp00797h ↗
32. 10.1016/j.biomaterials.2015.08.04510.1016/j.biomaterials.2015.08.045 ↗
33. 10.1021/acsbiomaterials.0c0097210.1021/acsbiomaterials.0c00972 ↗
34. 10.1038/nmat379410.1038/nmat3794 ↗
35. 10.1080/1040923029077154610.1080/10409230290771546 ↗
36. 10.1007/s10856-012-4731-210.1007/s10856-012-4731-2 ↗
37. 10.1039/c3tb20745e10.1039/c3tb20745e ↗
38. 10.1021/bm990017d10.1021/bm990017d ↗
39. 10.1002/mabi.20120047110.1002/mabi.201200471 ↗
40. 10.1002/adfm.20110166210.1002/adfm.201101662 ↗
41. 10.1039/c4ra02271h10.1039/c4ra02271h ↗
42. 10.1016/j.cej.2019.02.02010.1016/j.cej.2019.02.020 ↗
43. 10.1016/j.msec.2020.11074910.1016/j.msec.2020.110749 ↗
44. 10.1002/adma.20190434110.1002/adma.201904341 ↗
45. 10.1016/j.actbio.2017.11.01410.1016/j.actbio.2017.11.014 ↗
46. 10.1186/s40824-018-0149-310.1186/s40824-018-0149-3 ↗
47. 10.1042/BSR2019270810.1042/BSR20192708 ↗
48. 10.1007/s10753-020-01331-910.1007/s10753-020-01331-9 ↗
49. 10.1016/j.carbpol.2016.05.08810.1016/j.carbpol.2016.05.088 ↗
50. 10.1089/ten.teb.2008.008310.1089/ten.teb.2008.0083 ↗
51. 10.1038/ncomms1307310.1038/ncomms13073 ↗
52. 10.1002/advs.20190068310.1002/advs.201900683 ↗
53. 10.1359/jbmr.2003.18.9.170610.1359/jbmr.2003.18.9.1706 ↗
54. 10.1016/j.bone.2015.05.04610.1016/j.bone.2015.05.046 ↗
55. 10.1038/nmat109210.1038/nmat1092 ↗
56. 10.1016/j.biomaterials.2009.10.04010.1016/j.biomaterials.2009.10.040 ↗